NCT03063957

Brief Summary

The goal of this study is to establish a prospective observational cohort of adult patients with microscopic colitis and collect clinical information and specimens over the course of their treatment. This information will be used in order to establish a patient registry with detailed clinical data and a specimen repository for future research as well as to specifically identify genetic and molecular characteristics associated with microscopic colitis.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
330

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Jun 2015

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 30, 2015

Completed
1.6 years until next milestone

First Submitted

Initial submission to the registry

February 21, 2017

Completed
3 days until next milestone

First Posted

Study publicly available on registry

February 24, 2017

Completed
6.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 31, 2023

Completed
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

January 31, 2024

Completed
Last Updated

September 1, 2021

Status Verified

August 1, 2021

Enrollment Period

8.1 years

First QC Date

February 21, 2017

Last Update Submit

August 31, 2021

Conditions

Outcome Measures

Primary Outcomes (2)

  • Microbiome Analysis

    Standard 16s rRNA sequencing for taxonomic identification and metagenomic profiling of the gut microbiome will be performed on stool and tissue samples.

    1.5 years

  • Immune Response

    Immune cells in blood and biopsy samples will be sorted and quantified using flow cytometry

    1.5 years

Secondary Outcomes (1)

  • α4β7 in microscopic colitis pathogenesis

    2 years

Study Arms (2)

Microscopic Colitis

Patients with confirmed microscopic colitis

Control

Patients that are not diagnosed with microscopic colitis

Eligibility Criteria

Age18 Years+
Sexall
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients with suspected or established microscopic colitis who are scheduled to receive a diagnostic colonoscopy or attend an office visit at the MGH Gastroenterology Unit will be eligible for recruitment

You may qualify if:

  • Ability to give informed consent
  • Ability and willingness to comply with all patient visits and study-related procedures
  • Ability to understand and complete all study-related materials and questionnaires
  • Patients ages 18 or older with suspected microscopic colitis
  • Patients that have been previously treated for microscopic colitis that are being seen for possible relapse will also be included

You may not qualify if:

  • Inability to provide informed consent
  • Inability or unwillingness to comply with all patient visits and study-related procedures
  • Inability to understand and complete all study-related materials and questionnaires
  • Patients with a known diagnosis of Inflammatory Bowel Disease or colorectal cancer
  • Patients with a known bleeding disorder, acute disease, or those that are awaiting transplantation
  • Patients who have taken antibiotics in the last two weeks
  • Female subjects who are pregnant or nursing

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Massachusetts General Hospital

Boston, Massachusetts, 02114, United States

RECRUITING

Related Publications (8)

  • Brown WR, Tayal S. Microscopic colitis. A review. J Dig Dis. 2013 Jun;14(6):277-81. doi: 10.1111/1751-2980.12046.

    PMID: 23419063BACKGROUND
  • Chande N, MacDonald JK, McDonald JW. Interventions for treating microscopic colitis: a Cochrane Inflammatory Bowel Disease and Functional Bowel Disorders Review Group systematic review of randomized trials. Am J Gastroenterol. 2009 Jan;104(1):235-41; quiz 234, 242. doi: 10.1038/ajg.2008.16.

    PMID: 19098875BACKGROUND
  • Colussi D, Salari B, Stewart KO, Lauwers GY, Richter JR, Chan AT, Ricciardiello L, Khalili H. Clinical characteristics and patterns and predictors of response to therapy in collagenous and lymphocytic colitis. Scand J Gastroenterol. 2015;50(11):1382-8. doi: 10.3109/00365521.2015.1050692. Epub 2015 May 21.

    PMID: 25997458BACKGROUND
  • Jarnerot G, Hertervig E, Granno C, Thorhallsson E, Eriksson S, Tysk C, Hansson I, Bjorknas H, Bohr J, Olesen M, Willen R, Kagevi I, Danielsson A. Familial occurrence of microscopic colitis: a report on five families. Scand J Gastroenterol. 2001 Sep;36(9):959-62. doi: 10.1080/003655201750305486.

    PMID: 11521987BACKGROUND
  • Kao KT, Pedraza BA, McClune AC, Rios DA, Mao YQ, Zuch RH, Kanter MH, Wirio S, Conteas CN. Microscopic colitis: a large retrospective analysis from a health maintenance organization experience. World J Gastroenterol. 2009 Jul 7;15(25):3122-7. doi: 10.3748/wjg.15.3122.

    PMID: 19575491BACKGROUND
  • Khan MA, Brunt EM, Longo WE, Presti ME. Persistent Clostridium difficile colitis: a possible etiology for the development of collagenous colitis. Dig Dis Sci. 2000 May;45(5):998-1001. doi: 10.1023/a:1005593628991. No abstract available.

    PMID: 10795766BACKGROUND
  • LaSala PR, Chodosh AB, Vecchio JA, Schned LM, Blaszyk H. Seasonal pattern of onset in lymphocytic colitis. J Clin Gastroenterol. 2005 Nov-Dec;39(10):891-3. doi: 10.1097/01.mcg.0000180634.84689.c2.

    PMID: 16208113BACKGROUND
  • Yao MD, von Rosenvinge EC, Groden C, Mannon PJ. Multiple endoscopic biopsies in research subjects: safety results from a National Institutes of Health series. Gastrointest Endosc. 2009 Apr;69(4):906-10. doi: 10.1016/j.gie.2008.05.015. Epub 2009 Jan 10.

    PMID: 19136110BACKGROUND

Biospecimen

Retention: SAMPLES WITH DNA

Tissue, blood, stool

MeSH Terms

Conditions

Colitis, Microscopic

Condition Hierarchy (Ancestors)

ColitisGastroenteritisGastrointestinal DiseasesDigestive System DiseasesColonic DiseasesIntestinal Diseases

Study Officials

  • Hamed Khalili, MD

    Massachusetts General Hospital

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Hamed Khalili, MD

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Professor of Medicine at Harvard Medical School

Study Record Dates

First Submitted

February 21, 2017

First Posted

February 24, 2017

Study Start

June 30, 2015

Primary Completion

July 31, 2023

Study Completion

January 31, 2024

Last Updated

September 1, 2021

Record last verified: 2021-08

Data Sharing

IPD Sharing
Will not share

Only de-identified information may be shared with other collaborators and entities involved in generating data.

Locations